![BOE policy meeting, tech stocks, Tesla's EU sales - what's moving markets](https://i-invdn-com.investing.com/news/LYNXNPEB6U08A_S.jpg)
Please try another search
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Name | Age | Since | Title |
---|---|---|---|
Aditya Narayan | 69 | 2016 | Independent Non-Executive Chairman |
Rodolfo Hrosz | - | 2022 | MD & Director |
Usha Thorat | 73 | 2016 | Independent Non-Executive Director |
Rahul Bhatnagar | 65 | 2020 | Independent Director |
Vaibhav Karandikar | 50 | 2020 | Non-Executive Director |
Renee Amonkar | - | 2023 | Additional Whole Time Director |
Rachid Ayari | - | 2023 | CFO & Whole Time Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review